1-7 of 7
Maria Ken E. Figueroa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PDZD2 Is Required for Normal Erythropoiesis and Its 37-KDa Secreted Product, sPDZD2, Functions As a Soluble Tumor Suppressor in AML

Free
Marlise L Guerrero Schimpf, Michael S Pannullo, Courtney C Sparger, Hsuan-Ting Huang, Dean L Wade, Maria Ken E Figueroa
Journal: Blood
Blood (2023) 142 (Supplement 1): 2679.
https://doi.org/10.1182/blood-2023-190527
Published: 2023
Journal Articles

Arginine Methylation of BRD4 By CARM1 Regulates Its Function in AML

Free
Adnan K. Mookhtiar, Hidehiro Itonaga, Sarah Greenblatt, Concepcion Martinez, Jun Sun, Krystal Lisa Hossack, Ramin Shiekhattar, Daniel Bilbao, Maria Ken E. Figueroa, Simone Sidoli, Stephen D. Nimer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4112.
https://doi.org/10.1182/blood-2023-189759
Published: 2023
Journal Articles

Retinoic Acid and Ascorbate Remodel the Epigenome of Leukemia Cells to Improve Therapeutic Efficacy By Enhancing TET Activity

Free
Tiffany Leesang, Yoon Sing Yap, John P Brabson, Abigail Klimas, Emily L Ahearn, Daniela A Barbieri, Minh Quang Lam, Peter D Lyon, Maria Ken E. Figueroa, Felipe Beckedorff, Luisa Cimmino
Journal: Blood
Blood (2023) 142 (Supplement 1): 5706.
https://doi.org/10.1182/blood-2023-189774
Published: 2023
Journal Articles

DNA Methylation Profiles Capture Clinical and Molecular Heterogeneity of MDS and Can be Harnessed for the Development of Robust Biomarkers Predictive of Response to Azacitidine

Free
Qin Yang, Alice Brogi, Elizabeth A. Griffiths, Matilde Y Follo, Carlo Finelli, Jerald P. Radich, Michael J Rauh, Mikkael A. Sekeres, Rafael Bejar, Valeria Santini, Maria Ken E. Figueroa
Journal: Blood
Blood (2022) 140 (Supplement 1): 9769–9770.
https://doi.org/10.1182/blood-2022-163704
Published: 2022
Journal Articles

Corticotropin Releasing Hormone Binding Protein (CRHBP) Regulates Hematopoietic Function and Acts As a Novel AML Tumor Suppressor through a Crh-Independent Mechanism

Free
Daniela A Barbieri, Aristeidis G. Telonis, Maria Ken E. Figueroa
Journal: Blood
Blood (2022) 140 (Supplement 1): 5840–5841.
https://doi.org/10.1182/blood-2022-159719
Published: 2022
Journal Articles

XPO1 Overexpression Is a Mechanism of Resistance to Eprenetapopt and 5-Azacitidine Therapy That Can be Therapeutically Exploited for the Treatment of TP53 Mutated Myeloid Malignancies

Free
Traci L. Kruer, Ariel Quintana, Meghan Ferrall-Fairbanks, Ling Zhang, Hannah Newman, Amy F McLemore, Qin Yang, Nana Bencrentsil, Rami S. Komrokji, Sana Chaudhry, Tulasigeri M Totiger, Maria Ken E. Figueroa, Justin Taylor, David A. Sallman, Eric Padron
Journal: Blood
Blood (2022) 140 (Supplement 1): 99–100.
https://doi.org/10.1182/blood-2022-169765
Published: 2022
Journal Articles

PDZD2 Is Essential for Steady-State Hematopoiesis and Its 37-Kda Secreted Product, sPDZD2, Functions As a Soluble Tumor Suppressor in AML

Free
Marlise L Guerrero Schimpf, Courtney C. Sparger, Hsuan-Ting Huang, Dean Wade, Maria Ken E. Figueroa
Journal: Blood
Blood (2022) 140 (Supplement 1): 8696–8697.
https://doi.org/10.1182/blood-2022-171066
Published: 2022